
Omnipod® 5 System FDA-Cleared for Type 2 Diabetes
Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology with its Omnipod® brand, has announced that its Omnipod 5 Automated Insulin Delivery System is now FDA-cleared for adults with type 2 diabetes in the U.S. This makes Omnipod…













